Strongbridge Biopharma plc — Form D

Strongbridge Biopharma plc of TREVOSE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-14. The offering totals $126.0M, of which $126.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
A. Brian DavisExecutive OfficerWinston-Salem, NC
Stephen LongExecutive OfficerSan Francisco, CA
Robert LutzExecutive OfficerWoodinville, WA
Ruth Thieroff-EkerdtExecutive OfficerNew York, NY
Matthew PaulsDirectorDurham, NC
Matthew PaulsExecutive OfficerDurham, NC
BRIAN DAVISExecutive OfficerGRAFTON, WI
Garheng H KongDirectorSeattle, WA
Joseph M MahadyDirectorWarrington, PA
Steve LongExecutive OfficerOklahoma City, OK
Stephen Brian LongExecutive OfficerTrevose, PA
Jeffrey W ShermanDirectorTrevose, PA
Marten H SteenDirectorTrevose, PA
A. Brian DavisExecutive OfficerTrevose, PA
Fredric Brian CohenExecutive OfficerTrevose, PA
Richard H KollenderDirectorTrevose, PA
Robert Brian LutzExecutive OfficerTrevose, PA
Hilde H SteinegerDirectorTrevose, PA
H. Joseph ReiserDirectorVillanova, PA
Eigil Stray SpetalenDirectorTrevose, PA
Ernest Tidemann Eichenberg IIIDirectorRadnor, PA
Alexander LindstromExecutive OfficerRadnor, PA
Espen Tidemann JorgensenDirectorRadnor, PA
Marten Tidemann SteenDirectorRadnor, PA
John H JohnsonDirectorBranchburg, NJ

Other filings by this issuer (3)

FiledFormOfferingSold
2016-12-30D$35.0M$35.0M
2015-07-17D$33.2M$33.2M
2015-02-25D$26.4M$26.4M

More